Usefulness of intravenous enoxaparin for percutaneous coronary intervention in stable angina pectoris

This publication has 25 references indexed in Scilit:

• A Comparison of Low-Molecular-Weight Heparin with Unfractionated Heparin for Unstable Coronary Artery Disease
  New England Journal of Medicine, 1997
• Low-molecular-weight heparin during instability in coronary artery disease
  The Lancet, 1996
• Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia
  Journal of the American College of Cardiology, 1995
• Heparin-Induced Thrombocytopenia in Patients Treated with Low-Molecular-Weight Heparin or Unfractionated Heparin
  New England Journal of Medicine, 1995
• Comparison of efficacy of low molecular weight heparin (parnaparin) with that of unfractionated heparin in the presence of activated platelets in healthy subjects
  The American Journal of Cardiology, 1993
• Low-molecular-weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis
  The Lancet, 1992
• Low molecular weight heparin
  Blood, 1992
• Monitoring the effect of heparin by measurement of activated clotting time during and after percutaneous transluminal coronary angioplasty.
  Heart, 1990
• Adequate heparinization during PTCA: Assessment using activated clotting times
  Catheterization and Cardiovascular Diagnosis, 1989
• A Randomized Controlled Trial of a Low-Molecular-Weight Heparin (Enoxaparin) to Prevent Deep-Vein Thrombosis in Patients Undergoing Elective Hip Surgery
  New England Journal of Medicine, 1986